SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
24
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY) and Lead Plaintiff Deadline - February 19, 2019

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY ) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Dentsply shares between February 20, 2014 through August 7, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/xray .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933 and the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, specifically relating to its financial performance and its "innovation," "operational improvement efforts," "new products," and "continued investments in sales and marketing." The complaint alleges that: (1) Dentsply was engaged in an anticompetitive scheme among its three primary distributors that suppressed competition and artificially inflated the price of Dentsply's products; and (2) Dentsply engaged in "channel-stuffing" which rendered the Company's reported sales, financial results and guidance materially false and misleading.

On August 7, 2018, Dentsply divulged that it was under investigation by the Securities and Exchange Commission, revealed that three of its top executives were stepping down, lowered its guidance, and related disappointing financial results and a significant goodwill impairment charge.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site:  bgandg.com/xray or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Dentsply you have until February 19, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

CNB Financial Corporation Declares Exciting Dividend Update

Updated Category News Views 110

Overview of CNB Financial Corporation CNB Financial Corporation, a financial holding company, has recently declared a quarterly cash dividend of $0.18 per share for its common stock, underscoring its ongoing commitment to its shareholders. This dividend is set to be paid on an upcoming date to those shareholders who are recorded as of a specific cutoff date. As a...

Continue Reading
Transforming Clinical Trials with Wemedoo's oomnia® Partnership

Updated Category News Views 223

Revolutionizing Clinical Trials with a Strategic Partnership Across Global Alliance has forged a partnership with Wemedoo AG to leverage the oomnia platform as the backbone of its clinical trial infrastructure. This innovative move is anticipated to enhance operational efficiency, ensure regulatory compliance, and foster collaboration among its numerous alliance members...

Continue Reading
Shareholder Urges ADM's CEO to Resign Amid Concerns

Updated Category News Views 538

Concerns Raised Over ADM's Leadership A shareholder of Archer-Daniels-Midland (ADM) has sparked attention by calling for the resignation of CEO Juan Luciano. This plea follows an investigation that ADM disclosed regarding its accounting practices, raising red flags among investors and stakeholders. Background on the Shareholder's Claims The shareholder, Hartwig Fuchs, who...

Continue Reading
SPC Nickel Achieves High-Grade Nickel-Copper Intersections

Updated Category News Views 201

SPC Nickel Reports Exceptional Drill Results SPC Nickel Corp. is thrilled to share remarkable updates from its recent drilling program at the West Graham Project, located in a renowned nickel-copper mining region. The company has made significant strides in exploring and developing this rich mineral deposit. Highlights of the Drill Program During the drilling campaign,...

Continue Reading
Qualcomm's Market Dilemma: Balancing Optimism and Caution

Updated Category News Views 122

Qualcomm Faces Headwinds as Investor Sentiment Shifts Recently, shares of the renowned tech powerhouse Qualcomm (NASDAQ: QCOM) have encountered a significant downturn, highlighting a shift in investor sentiment that has caused concern among shareholders. The stock's value plummeted nearly 5% at the week's onset, landing below the $170 mark, representing a stark contrast...

Continue Reading